TUDCA was identified as a potential therapeutic drug for nonalcoholic steatohepatitis complicated with hypercholesterolemia targeting ADRA2C by integrated bioinformatics and experimental verification.
- DOI
- 10.1186/s13062-026-00926-w
- Published
- 2026 Aug 8
- Container
- Biology direct
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13062-026-00926-w,
title = {TUDCA was identified as a potential therapeutic drug for nonalcoholic steatohepatitis complicated with hypercholesterolemia targeting ADRA2C by integrated bioinformatics and experimental verification.},
author = {Liu H and Fan Y and Sun Z and Yuan S and Li B and Mi J and Lv S and Yang J and Zhai Y and Yuan Q},
year = {2026},
journal = {Biology direct},
doi = {10.1186/s13062-026-00926-w},
url = {https://doi.org/10.1186/s13062-026-00926-w}
}RIS
TY - JOUR TI - TUDCA was identified as a potential therapeutic drug for nonalcoholic steatohepatitis complicated with hypercholesterolemia targeting ADRA2C by integrated bioinformatics and experimental verification. AU - Liu H AU - Fan Y AU - Sun Z AU - Yuan S AU - Li B AU - Mi J AU - Lv S AU - Yang J AU - Zhai Y AU - Yuan Q PY - 2026 JO - Biology direct DO - 10.1186/s13062-026-00926-w UR - https://doi.org/10.1186/s13062-026-00926-w ER -
APA
H, L., Y, F., Z, S., S, Y., B, L., J, M., S, L., J, Y., Y, Z., & Q, Y. (2026). TUDCA was identified as a potential therapeutic drug for nonalcoholic steatohepatitis complicated with hypercholesterolemia targeting ADRA2C by integrated bioinformatics and experimental verification.. Biology direct. https://doi.org/10.1186/s13062-026-00926-w
Source records
- pubmed · retrieved 2026-11-10T14:48:34.868Z